tiprankstipranks
Trending News
More News >
Curative Biotechnology (CUBT)
OTHER OTC:CUBT
US Market

Curative Biotechnology (CUBT) Financial Statements

Compare
19 Followers

Curative Biotechnology Financial Overview

Curative Biotechnology's market cap is currently $7.19M. The company's EPS TTM is $-0.003; its P/E ratio is -6.33; Curative Biotechnology is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -92.21K$ -97.52K$ -7.96K$ -6.74K$ -5.30K
Operating Income$ -2.44M$ -1.93M$ -4.47M$ -5.01M$ -4.64M
EBITDA$ -2.35M$ -2.50M$ -4.36M$ -5.16M$ -4.60M
Net Income$ -3.56M$ -3.96M$ -5.38M$ -5.34M$ -4.67M
Balance Sheet
Cash & Short-Term Investments$ 19.53K$ 56.40K$ 58.67K$ 670.26K$ 160.61K
Total Assets$ 2.16M$ 2.60M$ 2.09M$ 2.41M$ 2.27M
Total Debt$ 1.37M$ 2.26M$ 1.07M$ 0.00$ 559.76K
Net Debt$ 1.35M$ 2.20M$ 1.01M$ -670.26K$ 399.15K
Total Liabilities$ 7.08M$ 5.75M$ 22.62M$ 18.77M$ 6.80M
Stockholders' Equity$ -4.91M$ -3.14M$ -2.54M$ 1.68M$ 1.61M
Cash Flow
Free Cash Flow$ -1.02M$ -500.63K$ -1.61M$ -1.63M$ -224.39K
Operating Cash Flow$ -1.02M$ -486.58K$ -1.54M$ -1.60M$ -190.09K
Investing Cash Flow$ 0.00$ -14.04K$ -76.91K$ -21.33K$ -34.30K
Financing Cash Flow$ 985.88K$ 498.36K$ 1.00M$ 2.14M$ 385.00K
Currency in USD

Curative Biotechnology Earnings and Revenue History

Curative Biotechnology Debt to Assets

Curative Biotechnology Cash Flow

Curative Biotechnology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.